Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment.

He J, Wang Y, Feng J, Zhu X, Lan X, Iyer AK, Zhang N, Seo Y, VanBrocklin HF, Liu B.

J Nucl Med. 2010 Mar;51(3):427-32. doi: 10.2967/jnumed.109.069492. Epub 2010 Feb 11.

2.

Monoclonal antibodies for cancer immunotherapy.

Weiner LM, Dhodapkar MV, Ferrone S.

Lancet. 2009 Mar 21;373(9668):1033-40. doi: 10.1016/S0140-6736(09)60251-8. Review.

3.

Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.

Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G 2nd, Samuel S, Kim MP, Lim SJ, Ellis LM.

Cancer Res. 2009 Mar 1;69(5):1951-7. doi: 10.1158/0008-5472.CAN-08-2023. Epub 2009 Feb 24.

4.

Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma.

Bidlingmaier S, He J, Wang Y, An F, Feng J, Barbone D, Gao D, Franc B, Broaddus VC, Liu B.

Cancer Res. 2009 Feb 15;69(4):1570-7. doi: 10.1158/0008-5472.CAN-08-1363. Epub 2009 Feb 3.

5.

Glioblastoma and stem cells.

Altaner C.

Neoplasma. 2008;55(5):369-74. Review.

PMID:
18665745
6.

Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids.

Ackerman ME, Pawlowski D, Wittrup KD.

Mol Cancer Ther. 2008 Jul;7(7):2233-40. doi: 10.1158/1535-7163.MCT-08-0067.

7.

Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance.

Thurber GM, Schmidt MM, Wittrup KD.

Adv Drug Deliv Rev. 2008 Sep;60(12):1421-34. doi: 10.1016/j.addr.2008.04.012. Epub 2008 Apr 24. Review.

8.

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis.

Eyler CE, Rich JN.

J Clin Oncol. 2008 Jun 10;26(17):2839-45. doi: 10.1200/JCO.2007.15.1829. Review.

9.

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.

Bidlingmaier S, Zhu X, Liu B.

J Mol Med (Berl). 2008 Sep;86(9):1025-32. doi: 10.1007/s00109-008-0357-8. Epub 2008 Jun 6. Review.

10.

Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells.

Westhoff MA, Zhou S, Bachem MG, Debatin KM, Fulda S.

Oncogene. 2008 Sep 4;27(39):5169-81. doi: 10.1038/onc.2008.148. Epub 2008 May 12.

PMID:
18469856
11.

The cancer stem cell-vascular niche complex in brain tumor formation.

Veeravagu A, Bababeygy SR, Kalani MY, Hou LC, Tse V.

Stem Cells Dev. 2008 Oct;17(5):859-67. doi: 10.1089/scd.2008.0047. Review.

PMID:
18429673
12.

Conventional and gene therapy strategies for the treatment of brain tumors.

Benítez JA, Domínguez-Monzón G, Segovia J.

Curr Med Chem. 2008;15(8):729-42. Review.

PMID:
18393842
13.

Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies.

An F, Drummond DC, Wilson S, Kirpotin DB, Nishimura SL, Broaddus VC, Liu B.

Mol Cancer Ther. 2008 Mar;7(3):569-78. doi: 10.1158/1535-7163.MCT-07-2132. Epub 2008 Mar 4.

14.

The emerging role of anti-angiogenic therapy for malignant glioma.

Reardon DA, Desjardins A, Rich JN, Vredenburgh JJ.

Curr Treat Options Oncol. 2008 Feb;9(1):1-22. doi: 10.1007/s11864-008-0052-6. Epub 2008 Feb 7. Review.

PMID:
18256938
15.

Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.

Chang JE, Khuntia D, Robins HI, Mehta MP.

Clin Adv Hematol Oncol. 2007 Nov;5(11):894-902, 907-15. Review.

PMID:
18185489
16.

Glioblastoma multiforme: evidence-based approach to therapy.

Nicholas MK.

Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S23-7. doi: 10.1586/14737140.7.12s.S23. Review.

PMID:
18076314
17.

Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells.

Roth A, Drummond DC, Conrad F, Hayes ME, Kirpotin DB, Benz CC, Marks JD, Liu B.

Mol Cancer Ther. 2007 Oct;6(10):2737-46.

18.

Long-term survival with glioblastoma multiforme.

Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G; German Glioma Network.

Brain. 2007 Oct;130(Pt 10):2596-606. Epub 2007 Sep 4. Review.

19.

Origins of breast cancer subtypes and therapeutic implications.

Sims AH, Howell A, Howell SJ, Clarke RB.

Nat Clin Pract Oncol. 2007 Sep;4(9):516-25. Review.

PMID:
17728710
20.

Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.

Liu B.

Brief Funct Genomic Proteomic. 2007 Jun;6(2):112-9. Epub 2007 Jul 31. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk